Clinical trial
Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in…
NCT00221195 · Tulane University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00221195 |
|---|---|
| Title | Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors |
| Official title | A Prospective, Randomized, Cross-over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors |
| Acronym | ProFEIBA |
| Lead sponsor | Tulane University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hemophilia A With Inhibitors |
| Intervention type | Drug |
| Interventions | activated prothrombin complex concentrate (FEIBA) |
| Enrollment | 34 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: